 
            IndraLab
Statements
                                      reach
                                
                                  
                                
                                
          
          
                                  "A study reported that, as novel MALT1 inhibitors, beta-lapachone analogs exhibited potent antiproliferative activity and inhibited the cleavage of CYLD mediated MALT1; this may be a promising therapeutic target for the treatment of aggressive subtype of diffuse large B-cell lymphoma [XREF_BIBR]."